Skip to main content

Day: March 4, 2025

Data443 Completes Operational Expense Rationalization

RESEARCH TRIANGLE PARK, N.C., March 04, 2025 (GLOBE NEWSWIRE) — Data443 Risk Mitigation, Inc. (OTCPK: ATDS) (“Data443” or the “Company”), an AI data security and privacy software company for “All Things Data Security,” today announced the completion of major operational expense rationalizations yielding immediate and long-term financial benefits. $3.1 Million in Annual Cost Savings Achieved “As part of our march toward profitability and operational efficiencies across all acquisitions, we have successfully eliminated over $3.1 million in annualized operational expenses from our current operations,” stated Jason Remillard, CEO of Data443. This cost optimization initiative follows the Company’s recent expansion in the AI sector, including an acquisition focused on email categorization and classification...

Continue reading

Cibus’ Achieves Another Milestone for a Durable White Mold (Sclerotinia) Resistance Trait in Canola

Initial bioassay data for Cibus’ third mode of action for white mold (Sclerotinia) resistance trait in canola shows promising results in controlled environment assessment Cibus’ white mold resistance traits are expected to help preserve crop yields and reduce fungicide usage for farmers SAN DIEGO, March 04, 2025 (GLOBE NEWSWIRE) — Cibus, Inc. (Nasdaq: CBUS) (the “Company”), a leading agricultural technology company that develops and licenses plant traits to seed companies for royalties, today announced that controlled environment testing of its third mode of action (MOA) for its Sclerotinia resistance trait in Canola demonstrated enhanced resistance. The core of Cibus’ gene editing technology is its Rapid Trait Development System™ or RTDS®. It is a system of proprietary technologies that integrates crop specific cell biology...

Continue reading

Pharming Group reports on results of the 2025 Extraordinary General Meeting of Shareholders

Leiden, the Netherlands, March 4, 2025: Pharming Group N.V. (“Pharming” or “the Company”) (EURONEXT Amsterdam: PHARM/Nasdaq: PHAR) announces today that the Extraordinary General Meeting of Shareholders (EGM) has adopted all proposals on the EGM agenda. Shareholders approved the appointment of Mr. Fabrice Chouraqui as Executive Director and Chief Executive Officer for a term of four years. As a result, Mr. Chouraqui succeeds Mr. Sijmen de Vries with immediate effect. To ensure a smooth hand-over of tasks and responsibilities, Mr. de Vries will remain a strategic advisor to the new CEO until December 31, 2025. In addition, shareholders also approved the proposal to approve certain components of the remuneration package of Mr. Chouraqui in his capacity as Executive Director and Chief Executive Officer. A recording of the webcast, presentation...

Continue reading

Hollywood Star Cuts Brings the Movie Star Experience to the UK!

LAS VEGAS, March 04, 2025 (GLOBE NEWSWIRE) — All American Gold Corp. (OTC: AAGC) is elated to update the public about Hollywood Star Cuts’ aggressive growth into the European market. On February 23rd, 2025, AAGC and Hollywood Star Cuts formally entered an agreement with a franchise group from England to develop the Hollywood Star Cuts model throughout the United Kingdom. In late January 2025, Hollywood Star Cuts was approached by a team of successful entrepreneurs based in London England. This particular group had been instrumental in importing and developing Fast Food brands from America, Breakfast brands from Canada as well as others. Hollywood Star Cuts and the English development group utilized the previous month to establish an agreement that will ensure their success while increasing revenues and worldwide exposure for Hollywood...

Continue reading

49-Year Business Graphics 3 Sold to New Minuteman Press Franchise Owner Tyler Griffith in Coldwater, MI

Minuteman Press Franchise Coldwater, MINew Minuteman Press Franchise Owner Tyler Griffith (left) has purchased 49-year business Graphics 3 from Mike Iveson (right). Moving forward, the business is operating as Minuteman Press in Coldwater, MI.COLDWATER, Mich., March 04, 2025 (GLOBE NEWSWIRE) — Graphics 3, a second-generation printing business owned by Iveson family for 49 years, has been sold by retiring owner Mike Iveson to new Minuteman Press franchise owner Tyler Griffith. Moving forward, the business will operate as Minuteman Press in Coldwater and remains located at 205 W. Garfield Avenue, Coldwater, MI 49036. On selling the business, Mike shares, “Tyler Griffith has been great to work with, allowing me to decompress from owner to bystander. The transition has been even better than I expected and everything has worked...

Continue reading

Alumis and ACELYRIN Reaffirm Strategic and Financial Rationale of Proposed Merger

Combined company to benefit from differentiated late-stage portfolio of therapies and strong balance sheet SOUTH SAN FRANCISCO, Calif. and LOS ANGELES, March 04, 2025 (GLOBE NEWSWIRE) — Alumis Inc. (Nasdaq: ALMS) (“Alumis”) and ACELYRIN, INC. (Nasdaq: SLRN) (“ACELYRIN”) today reaffirmed their commitment to merge in an all-stock transaction, which will create a leading clinical stage biopharma company in immune-mediated diseases. Martin Babler, President, Chief Executive Officer and Chairman of Alumis, said, “Alumis and ACELYRIN together will advance exciting breakthroughs for patients and drive long-term value for stockholders through the creation of a leading clinical stage biopharma company in immune-mediated diseases. The combined company will have a significantly strengthened financial position to support a highly differentiated...

Continue reading

ACELYRIN and Alumis Reaffirm Strategic and Financial Rationale of Proposed Merger

Combined company to benefit from differentiated late-stage portfolio of therapies and strong balance sheet LOS ANGELES and SOUTH SAN FRANCISCO, Calif., March 04, 2025 (GLOBE NEWSWIRE) — ACELYRIN, INC. (Nasdaq: SLRN) and Alumis Inc. (Nasdaq: ALMS) today reaffirmed their commitment to merge in an all-stock transaction, which will create a leading clinical stage biopharma company in immune-mediated diseases. Martin Babler, President, Chief Executive Officer and Chairman of Alumis, said, “Alumis and ACELYRIN together will advance exciting breakthroughs for patients and drive long-term value for stockholders through the creation of a leading clinical stage biopharma company in immune-mediated diseases. The combined company will have a significantly strengthened financial position to support a highly differentiated and diverse pipeline...

Continue reading

Primech AI Launches Global Robotics as a Service (RaaS) Initiative with Chinachem Group Partnership

                                                                                    Pioneering AI-Powered Cleaning Technology Deployment Marks Strategic Expansion into Hong Kong Market SINGAPORE, March 04, 2025 (GLOBE NEWSWIRE) — Primech AI Pte. Ltd. (“Primech AI”) or (the “Company”), a subsidiary of Primech Holdings Limited (Nasdaq: PMEC), is proud to announce the launch of its innovative Robotics as a Service (RaaS) business line, revolutionizing the cleaning solutions industry. This strategic initiative addresses critical industry challenges including labor shortages, hygiene standards, and operational costs through proprietary AI-driven technology. As part of this global expansion strategy, Primech AI has signed a Memorandum of Understanding (MoU) with CCG Property Services, a subsidiary of Hong Kong’s leading...

Continue reading

Montero Receives Final Instalment of US$7 million from Tanzania

TORONTO, March 04, 2025 (GLOBE NEWSWIRE) — Montero Mining and Exploration Ltd. (TSX-V: MON) (“Montero” or the “Company”) is pleased to confirm that US$7,000,000 in cash (the “Final Instalment”) have been received by the Company from the United Republic of Tanzania (“Tanzania”). This payment represents the final instalment of the US$27,000,000 settlement between the Company and Tanzania and is expected to put an end to the dispute in connection with Tanzania’s expropriation of Montero’s Wigu Hill rare earth element project before the International Centre for Settlement of Investments Disputes (“ICSID”). The final net proceeds to be received by the Company is not certain at this time as final legal costs and other expenses Montero incurred in connection with defence and settlement of the Expropriation will now be determined as the...

Continue reading

Form 8.3 – Warehouse REIT Plc

8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: Rathbones Group Plc(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.  (c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree Warehouse REIT Plc(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:  (e)   Date position held/dealing undertaken:        For an opening position...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.